Learn about the types of warning letters on FDA's website.
Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request. Frequently requested records may be accessed on the Reading Room page.
Posted Date Letter Issue Date Company Name Issuing Office Subject Response Letter Closeout Letter Excerpt 07/28/2026 06/08/2026 Delight Distribution Inc. Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP) 07/28/2026 07/02/2026 Piquin Y Sabores Distributors LLC Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP) 07/28/2026 07/16/2026 San Jorge Produce LLC Human Foods Program Foreign Supplier Verification Program (FSVP) 07/28/2026 04/10/2026 Prida Import & Export LLC Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP) 07/28/2026 06/12/2026 AHC Products, Inc. Center for Veterinary Medicine CGMP/Finished Pharmaceuticals/Adulterated 07/28/2026 07/09/2026 VasoCorp, Inc. Human Foods Program Unapproved New Drugs/Misbranded 07/28/2026 07/23/2026 Eherbs Imports, Inc Office of Inspections and Investigations Foreign Supplier Verification Program (FSVP) 07/22/2026 05/27/2026 Linemaster Switch Corporation Center for Devices and Radiological Health CGMP/QSR/Drug/Medical Devices/Adulterated 07/21/2026 07/10/2026 Pratik Doshi, M.D. / Alembic Pharmaceuticals Ltd. Center for Drug Evaluation and Research (CDER) In Vivo Bioavailability-Bioequivalence Studies – Clinical 07/21/2026 04/10/2026 Fareva Amboise Center for Veterinary Medicine CGMP/Finished Pharmaceuticals/Adulterated